Patients are at risk for heart disease, kidney failure, limb amputation and other serious complications.
患者面临心脏疾病、肾衰竭、肢端坏死以及其它严重并发症的风险。
Patients in lower socioeconomic positions had more atherosclerosis, serious cardiovascular disease, prior heart attacks, left ventricular dysfunction and heart failure.
社会经济地位较低的患者有更多的动脉粥样硬化，严重的心血管疾病，心脏病发作先兆，左心功能不全，心力衰竭。
Serious heart failure is increased in patients on pioglitazone, although there is no associated increase in mortality.
在使用匹格列酮的患者中，严重的心力衰竭增加，但是没有引起与之相关的死亡率的增加。
应用推荐